Health & Medicine

6
facebook twitter google print email
Media Contact:Evan Lerner | elerner@upenn.edu | 215-573-6604May 7, 2015

Penn Research Points to Omega-3 as a Nutritional Intervention for Childhood Behavioral Problems

At the forefront of a field known as “neurocriminology,” Adrian Raine of the University of Pennsylvania has long studied the interplay between biology and environment when it comes to antisocial and criminal behavior.

facebook twitter google print email
Media Contact:Evan Lerner | elerner@upenn.edu | 215-573-6604May 7, 2015

Penn Researchers Develop Custom Artificial Membranes to Study the Molecular Basis of Disease

blurb: 
Decorating the outside of cells like tiny antenna, a diverse community of sugar molecules acts like a telecommunications system, sending and receiving information, recognizing and responding to foreign molecules and neighboring cells.

By Madeleine Stone  @themadstone       

Decorating the outside of cells like tiny antenna, a diverse community of sugar molecules acts like a telecommunications system, sending and receiving information, recognizing and responding to foreign molecules and neighboring cells.

facebook twitter google print email
Media Contact:Katherine Unger Baillie | kbaillie@upenn.edu | 215-898-9194May 6, 2015

Penn-Michigan State Team Develops Novel Gene Therapy for Achromatopsia

blurb: 
Researchers from the University of Pennsylvania and Michigan State University tested a gene therapy in dogs with achromatopsia and found that the treatment demonstrated a functional rescue of cone cells in nearly 100 percent of treated eyes.

Researchers from the University of Pennsylvania and Michigan State University presented new preclinical data this week that evaluates the efficacy of a gene therapy treatment for achromatopsia, a rare inherited retinal disease that involves cone cells. The disease affects humans as well as dogs.

facebook twitter google print email
Media Contact:Karen Kreeger | karen.kreeger@uphs.upenn.edu | 215-349-5658April 30, 2015

NIH Awards $8 Million Renewal to Penn Medicine's Center of Excellence in Environmental Toxicology

The National Institutes of Environmental Health Sciences (NIEHS), part of the National Institutes of Health (NIH), has renewed its funding to the Center of Excellence in Environmental Toxicology (CEET), at the University of Pennsylvania’s Perelman School of Medicine, for the next five years.

facebook twitter google print email
Media Contact:Steve Graff | stephen.graff@uphs.upenn.edu | 215-349-5653May 4, 2015

Penn Medicine Researchers Receive $7.5 Million to Expand HIV Gene Therapy Work

Researchers from the Perelman School of Medicine and the Penn Center for AIDS Research (CFAR) have been awarded $7.5 million over five years from the National Institutes of Health to initiate a multi-project HIV study investigating a new gene therapy approach to render immune cells of HIV positive patients resistant to the virus.

facebook twitter google print email
Media Contact:Steve Graff | stephen.graff@uphs.upenn.edu | 215-349-5653April 29, 2015

Medical Education Risks Becoming Two-Tiered Unless Strong Research Focus is Preserved, Argue Philadelphia Medical Leaders

For more than 100 years, exposing students to basic and clinical research has been an essential component of a medical school education in the United States. However, today, new models of medical education in which research plays a minimal role are likely to create a two-tiered system of education, decrease the physician-scientist pipeline and diminish the application of scientific advances to patient care.

facebook twitter google print email
Media Contact:Lee-Ann Donegan | leeann.donegan@uphs.upenn.edu | 215-349-5660May 4, 2015

Penn Study Indicates that Gene Therapy Efficacy for LCA is Dynamic: Improvement is Followed by Decline in Vision

Gene therapy for Leber congenital amaurosis (LCA), an inherited disorder that causes loss of night- and day-vision starting in childhood, improved patients’ eyesight within weeks of treatment in a clinical trial of 15 children and adults at the Scheie Eye Institute at the Perelman School of Medicine at the University of Pennsylvania.

facebook twitter google print email
Media Contact:Anna Duerr | anna.duerr@uphs.upenn.edu | 215-349-8369May 4, 2015

Restored Sight Fades After Gene Therapy

May 5, 2015

Samuel Jacobson and Jean Bennett of the Perelman School of M

Article Source: The Scientist

Penn Study Questions Lariat Device to Prevent Stroke in Heart Patients

May 5, 2015

Jay Giri of the Perelman School of Medicine says, “The Lariat is an absolutely ingenious piece of engineering… However,

Article Source: Philadelphia Inquirer